Substance
ID:73327
Names and Identifiers
IUPAC name
2-ethoxy-4-({[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]carbamoyl}methyl)benzoic acid
IUPAC Traditional name
repaglinide
Synonyms
RepaglinidePrandinGlucoNormNovoNorm
Registration numbers
CAS Number
Properties
Safety Information
Storage Condition
-20°C
Pharmacology Properties
Target
potassium channel
Product Information
Salt Data
Free Base
Molecule Details
Research Area: Endocrinology
Biological Activity:
Repaglinide is for the treatment of type II diabetes. Repaglinide belongs to the meglitinide class of blood glucose-lowering drugs. Repaglinide lowers blood glucose by stimulating the release of insulin from the pancreas. It achieves this by closing ATP-dependent potassium channels in the membrane of the beta cells. [1]
Biological Activity:
Repaglinide is for the treatment of type II diabetes. Repaglinide belongs to the meglitinide class of blood glucose-lowering drugs. Repaglinide lowers blood glucose by stimulating the release of insulin from the pancreas. It achieves this by closing ATP-dependent potassium channels in the membrane of the beta cells. [1]
Molecular Spectra
No Data Available
Click here to submit data
References
• http://en.wikipedia.org/wiki/Repaglinide